Overview
This clinical trial will try to determine if the supplements magnesium and riboflavin will reduce the pain and duration of headaches in persons diagnosed with a concussion. The participant will be randomized to either active magnesium and riboflavin capsules or placebo (inert) capsules. The capsules will be taken once a day for 14 days. The participant will also complete a short diary form for the 14 days and will have 3 follow up visits either by telephone or in person.
Eligibility
Inclusion Criteria:
- Seen at University of Virginia Student Health and Wellness Center or Emergency Department for Initial Visit for Concussion;
- Less than 3 days have elapsed since their injury;
- Able to swallow capsules
Exclusion Criteria:
- Concussion complicated by cranial bleed, skull fracture, additional severe injury;
- Kidney disfunction or failure;
- Significant gastro-intestinal dysfunction;
- Varsity Athlete;
- Two or more previous concussions;
- Women who are pregnant or breast feeding;
- Taking tetracycline, fluoroquinolone, iron digoxin, chlorpromazine or penicillamine